Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

5(45%)

Results Posted

33%(1 trials)

Terminated

1(9%)

Phase Distribution

Ph early_phase_1

18%

Ph not_applicable

36%

Ph phase_1

Ph phase_2

36%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Early Phase 1First-in-human

2(18.2%)

Phase 1Safety & dosage

1(9.1%)

Phase 2Efficacy & side effects

4(36.4%)

N/ANon-phased studies

4(36.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(5)

Completed(3)

Terminated(2)

Other(1)

Detailed Status

Recruiting5

Completed3

Terminated1

unknown1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 2

Trials by Phase

Early Phase 12 (18.2%)

Phase 11 (9.1%)

Phase 24 (36.4%)

N/A4 (36.4%)

Trials by Status

terminated19%

unknown19%

withdrawn19%

completed327%

recruiting545%

Recent Activity

5 active trials

Showing 5 of 11

recruitingnot_applicable

Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients

NCT06922825

View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials

NCT06275477Not Applicable

68Gallium-FAPI46 PET/CT Imaging in Chronic Inflammatory and Fibrotic Diseases

Recruiting

NCT05262855Phase 2

Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma

Completed

NCT05903807Phase 2

[68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer

Terminated

NCT05617742Not Applicable

Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer

Completed

NCT06922825Early Phase 1

Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients

Withdrawn

NCT05898854Phase 2

[68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer

Completed

NCT05365802Early Phase 1

FAPI PET for Lung Fibrosis

Recruiting

NCT06604260Phase 2

FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients

Recruiting

NCT06232122Not Applicable

Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer

Recruiting

NCT05263700Not Applicable

FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary

Unknown

NCT05172310Phase 1

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

Recruiting

All 11 trials loaded

Drug Details

Intervention Type: DIAGNOSTIC TEST
Total Trials: 11